Lixte Biotechnology Holdings, Inc. (LIXT)
LIXT Stock Price Chart
Explore Lixte Biotechnology Holdings, Inc. interactive price chart. Choose custom timeframes to analyze LIXT price movements and trends.
LIXT Company Profile
Discover essential business fundamentals and corporate details for Lixte Biotechnology Holdings, Inc. (LIXT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Oct 2007
Employees
2.00
Website
https://lixte.comCEO
Bastiaan van der Baan
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.
LIXT Financial Timeline
Browse a chronological timeline of Lixte Biotechnology Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 7 Aug 2025
EPS came in at -$0.29 .
Earnings released on 12 May 2025
EPS came in at -$0.29 .
Earnings released on 24 Mar 2025
EPS came in at -$0.27 .
Earnings released on 12 Nov 2024
EPS came in at -$0.44 .
Earnings released on 8 Aug 2024
EPS came in at -$0.45 .
Earnings released on 9 May 2024
EPS came in at -$0.43 .
Earnings released on 19 Mar 2024
EPS came in at -$0.41 .
Earnings released on 9 Nov 2023
EPS came in at -$0.49 .
Earnings released on 9 Aug 2023
EPS came in at -$1.00 .
Stock split effective on 5 Jun 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 May 2023
EPS came in at -$0.80 .
Earnings released on 29 Mar 2023
EPS came in at -$1.00 .
Earnings released on 8 Nov 2022
EPS came in at -$0.90 .
Earnings released on 10 Aug 2022
EPS came in at -$1.00 .
Earnings released on 11 May 2022
EPS came in at -$1.20 .
Earnings released on 21 Mar 2022
EPS came in at -$1.50 .
Earnings released on 10 Nov 2021
EPS came in at -$0.90 .
Earnings released on 10 Aug 2021
EPS came in at -$1.27 .
Earnings released on 12 May 2021
EPS came in at -$1.35 .
Earnings released on 26 Mar 2021
EPS came in at -$0.78 .
Stock split effective on 20 Nov 2020
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Nov 2020
EPS came in at -$1.43 .
LIXT Stock Performance
Access detailed LIXT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.